SymbolLUDG
NameLUDWIG ENTERPRISES, INC.
SectorUNDEFINED
RegionNorth America
Industry-
Address33156 United States FL 8950 SW 74th Ct Ste 2201-A149
Telephone786-363-0166
Fax
Email
Websitehttp://www.ludwigent.com
IncorporationUS
Incorporated On2007
Employees
Fiscal Year12/31
Public Since
ExchangesOTC;NASDAQ
AuditorAssurance Dimensions;Stephano Slack LLC;
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001960262
Description

About Ludwig Enterprises, Inc.: Advancements in genomic technology have awarded us with cutting-edge genetic tools, unheard-of even a generation ago. These genetic tools have the potential to not only detect diseases early but also monitor response to treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era of medicine with their proprietary mRNA genomic technology that has the potential to measure genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, preeclampsia, and cancer. This early detection may allow doctors to take steps to diagnose and manage disease before it progresses and causes serious health problems. Ludwigs innovative testing approach is not only practical but also has the potential to save the healthcare industry millions of dollars in costs. With a virtually untapped market and a multi billion-dollar healthcare industry, Ludwig is poised to significantly impact how we think about disease and live longer, healthier lives. More Info: http://www.ludwigent.com

Additional info from OTC:
About Ludwig Enterprises, Inc.: Advancements in genomic technology have awarded us with cutting-edge genetic tools, unheard-of even a generation ago. These genetic tools have the potential to not only detect diseases early but also monitor response to treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era of medicine with their proprietary mRNA genomic technology that has the potential to measure genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, preeclampsia, and cancer. This early detection may allow doctors to take steps to diagnose and manage disease before it progresses and causes serious health problems. Ludwigs innovative testing approach is not only practical but also has the potential to save the healthcare industry millions of dollars in costs. With a virtually untapped market and a multi billion-dollar healthcare industry, Ludwig is poised to significantly impact how we think about disease and live longer, healthier lives. More Info: http://www.ludwigent.com

2024-08-30 04:28

Pink Current symbol attribute type Security_Name was changed. Previous value: -. New value: LUDWIG ENTERPRISES.

Read more
2024-08-27 08:16

OTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: LUDWIG ENTERPRISES.

Read more
2023-06-21 16:47

June 21, 2023 Amendment to Form S-1 – Registration Statement Under The Securities Act Of 1933 – Ludwig Enterprises, Inc. – 47,000,000 Shares of Common Stock

Read more